Showing 1 - 10 of 10
Economists think of medical innovation as a valuable but risky good, producing health benefits but increasing financial risk. This perspective overlooks how innovation can lower physical risks borne by healthy patients facing the prospect of future disease. We present an alternative framework...
Persistent link: https://www.econbiz.de/10011201890
In a complex economy, production is vertical and crosses jurisdictional lines. Goods are often produced by an upstream national or global firm and improved or distributed by local firms downstream. In this context, heightened products liability may have unintended consequences on product sales...
Persistent link: https://www.econbiz.de/10010796666
Persistent link: https://www.econbiz.de/10001171239
Persistent link: https://www.econbiz.de/10010502731
Persistent link: https://www.econbiz.de/10011745194
Persistent link: https://www.econbiz.de/10010339560
Vaccination is a critical tool, along with suppression and treatment, for controlling epidemics such as SARS-CoV-2. To maximize the impact of vaccination, doses should be allocated to the highest value targets, accounting for health and potential economic benefits. We examine what allocation...
Persistent link: https://www.econbiz.de/10012814457
Persistent link: https://www.econbiz.de/10012504425
Economists think of medical innovation as a valuable but risky good, producing health benefits but increasing financial risk. This perspective overlooks how innovation can lower physical risks borne by healthy patients facing the prospect of future disease. We present an alternative framework...
Persistent link: https://www.econbiz.de/10012457653
In a complex economy, production is vertical and crosses jurisdictional lines. Goods are often produced by a global or national firm upstream and improved or distributed by local firms downstream. In this context, heightened products liability may have unintended consequences for consumer...
Persistent link: https://www.econbiz.de/10013056589